{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:58:54Z","timestamp":1790384334895,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:00:00Z","timestamp":1784419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:00:00Z","timestamp":1784419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00405-026-10456-w","type":"journal-article","created":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T21:19:52Z","timestamp":1784495992000},"page":"6637-6650","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive evaluation of angiogenesis-associated genes in papillary thyroid cancer using bulk RNA and single-cell sequencing data"],"prefix":"10.1007","volume":"283","author":[{"given":"Jun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Xin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2006-9645","authenticated-orcid":false,"given":"Xiao-Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,19]]},"reference":[{"key":"10456_CR1","doi-asserted-by":"crossref","unstructured":"Melaccio A, Sgaramella LI, Pasculli A, Di Meo G, Gurrado A, Prete FP et al (2021) Prognostic and therapeutic role of angiogenic microenvironment in thyroid cancer. Cancers (Basel) 13:2775","DOI":"10.3390\/cancers13112775"},{"key":"10456_CR2","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.omtn.2021.02.027","volume":"24","author":"Y Wang","year":"2021","unstructured":"Wang Y, Cen A, Yang Y, Ye H, Li J, Liu S et al (2021) miR-181a, delivered by hypoxic PTC-secreted exosomes, inhibits DACT2 by downregulating MLL3, leading to YAP-VEGF-mediated angiogenesis. Mol Ther Nucleic Acids 24:610\u2013621","journal-title":"Mol Ther Nucleic Acids"},{"key":"10456_CR3","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1186\/s12935-021-02323-x","volume":"21","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wang C, Fu Z, Zhang S, Chen J (2021) miR-30b-5p inhibits proliferation, invasion, and migration of papillary thyroid cancer by targeting GALNT7 via the EGFR\/PI3K\/AKT pathway. Cancer Cell Int 21:618","journal-title":"Cancer Cell Int"},{"key":"10456_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13148-017-0346-2","volume":"9","author":"CM Beltrami","year":"2017","unstructured":"Beltrami CM, Dos Reis MB, Barros-Filho MC, Marchi FA, Kuasne H, Pinto CAL et al (2017) Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas. Clin Epigenetics 9:45","journal-title":"Clin Epigenetics"},{"key":"10456_CR5","doi-asserted-by":"publisher","first-page":"112626","DOI":"10.1016\/j.yexcr.2021.112626","volume":"404","author":"L Chen","year":"2021","unstructured":"Chen L, Sun Z, Xu H, Xie Q, Qi M, Tian X et al (2021) Emerging roles of circular RNAs in thyroid cancer. Exp Cell Res 404:112626","journal-title":"Exp Cell Res"},{"key":"10456_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1507\/endocrj.EJ18-0537","volume":"66","author":"S Rajabi","year":"2019","unstructured":"Rajabi S, Dehghan MH, Dastmalchi R, Jalali Mashayekhi F, Salami S, Hedayati M (2019) The roles and role-players in thyroid cancer angiogenesis. Endocr J 66:277\u2013293","journal-title":"Endocr J"},{"key":"10456_CR7","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.1210\/jc.2004-1260","volume":"89","author":"S Hoffmann","year":"2004","unstructured":"Hoffmann S, Hofbauer LC, Scharrenbach V, Wunderlich A, Hassan I, Lingelbach S et al (2004) Thyrotropin (TSH)-induced production of vascular endothelial growth factor in thyroid cancer cells in vitro: evaluation of TSH signal transduction and of angiogenesis-stimulating growth factors. J Clin Endocrinol Metab 89:6139\u20136145","journal-title":"J Clin Endocrinol Metab"},{"key":"10456_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00423-006-0104-y","volume":"391","author":"S Hoffmann","year":"2006","unstructured":"Hoffmann S, Gl\u00e4ser S, Wunderlich A, Lingelbach S, Dietrich C, Burchert A et al (2006) Targeting the EGF\/VEGF-R system by tyrosine-kinase inhibitors\u2013a novel antiproliferative\/antiangiogenic strategy in thyroid cancer. Langenbecks Arch Surg 391:589\u2013596","journal-title":"Langenbecks Arch Surg"},{"key":"10456_CR9","first-page":"1495","volume":"17","author":"W Jia","year":"2013","unstructured":"Jia W, Gao XJ, Zhang ZD, Yang ZX, Zhang G (2013) S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF. Eur Rev Med Pharmacol Sci 17:1495\u20131508","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10456_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3892\/mmr.2012.1166","volume":"7","author":"BH Park","year":"2013","unstructured":"Park BH, Jung KH, Son MK, Seo JH, Lee HS, Lee JH et al (2013) Antitumor activity of Pulsatilla koreana extract in anaplastic thyroid cancer via apoptosis and anti-angiogenesis. Mol Med Rep 7:26\u201330","journal-title":"Mol Med Rep"},{"key":"10456_CR11","first-page":"5191","volume":"18","author":"GH Shi","year":"2018","unstructured":"Shi GH, Zhou L (2018) Emodin suppresses angiogenesis and metastasis in anaplastic thyroid cancer by affecting TRAF6\u2013mediated pathways in vivo and in vitro. Mol Med Rep 18:5191\u20135197","journal-title":"Mol Med Rep"},{"key":"10456_CR12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41416-021-01340-x","volume":"125","author":"J Liang","year":"2021","unstructured":"Liang J, Jin Z, Kuang J, Feng H, Zhao Q, Yang Z et al (2021) The role of anlotinib-mediated EGFR blockade in a positive feedback loop of CXCL11-EGF-EGFR signalling in anaplastic thyroid cancer angiogenesis. Br J Cancer 125:390\u2013401","journal-title":"Br J Cancer"},{"key":"10456_CR13","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1158\/1535-7163.MCT-06-0595","volume":"6","author":"S Kim","year":"2007","unstructured":"Kim S, Yazici YD, Calzada G, Wang ZY, Younes MN, Jasser SA et al (2007) Sorafenib inhibits the angiogenesis and growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice. Mol Cancer Ther 6:1785\u20131792","journal-title":"Mol Cancer Ther"},{"key":"10456_CR14","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1093\/hmg\/ddp135","volume":"18","author":"E Org","year":"2009","unstructured":"Org E, Eyheramendy S, Juhanson P, Gieger C, Lichtner P, Klopp N et al (2009) Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations. Hum Mol Genet 18:2288\u20132296","journal-title":"Hum Mol Genet"},{"key":"10456_CR15","doi-asserted-by":"publisher","first-page":"C821","DOI":"10.1152\/ajpcell.00326.2022","volume":"324","author":"B Dasen","year":"2023","unstructured":"Dasen B, Pigeot S, Born GM, Verrier S, Rivero O, Dittrich PS et al (2023) T-cadherin is a novel regulator of pericyte function during angiogenesis. Am J Physiol Cell Physiol 324:C821\u2013c836","journal-title":"Am J Physiol Cell Physiol"},{"key":"10456_CR16","doi-asserted-by":"publisher","first-page":"a003129","DOI":"10.1101\/cshperspect.a003129","volume":"1","author":"G Berx","year":"2009","unstructured":"Berx G, van Roy F (2009) Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol 1:a003129","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10456_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12964-021-00728-9","volume":"19","author":"W Zheng","year":"2021","unstructured":"Zheng W, Zhang S, Guo H, Chen X, Huang Z, Jiang S et al (2021) Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma. Cell Commun Signal 19:39","journal-title":"Cell Commun Signal"},{"key":"10456_CR18","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1038\/jid.2012.131","volume":"132","author":"E Kyriakakis","year":"2012","unstructured":"Kyriakakis E, Maslova K, Philippova M, Pfaff D, Joshi MB, Buechner SA et al (2012) T-Cadherin is an auxiliary negative regulator of EGFR pathway activity in cutaneous squamous cell carcinoma: impact on cell motility. J Invest Dermatol 132:2275\u20132285","journal-title":"J Invest Dermatol"},{"key":"10456_CR19","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1096\/fj.14-249367","volume":"29","author":"K Maslova","year":"2015","unstructured":"Maslova K, Kyriakakis E, Pfaff D, Frachet A, Frismantiene A, Bubendorf L et al (2015) EGFR and IGF-1R in regulation of prostate cancer cell phenotype and polarity: opposing functions and modulation by T-cadherin. Faseb j 29:494\u2013507","journal-title":"Faseb j"},{"key":"10456_CR20","doi-asserted-by":"publisher","first-page":"e1005332","DOI":"10.1371\/journal.pcbi.1005332","volume":"13","author":"H Bazzazi","year":"2017","unstructured":"Bazzazi H, Popel AS (2017) Computational investigation of sphingosine kinase 1 (SphK1) and calcium dependent ERK1\/2 activation downstream of VEGFR2 in endothelial cells. PLoS Comput Biol 13:e1005332","journal-title":"PLoS Comput Biol"},{"key":"10456_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13578-018-0204-8","volume":"8","author":"KS Hsu","year":"2018","unstructured":"Hsu KS, Kao HY (2018) PML: Regulation and multifaceted function beyond tumor suppression. Cell Biosci 8:5","journal-title":"Cell Biosci"},{"key":"10456_CR22","doi-asserted-by":"publisher","first-page":"10048","DOI":"10.1074\/jbc.M116.771071","volume":"292","author":"KS Hsu","year":"2017","unstructured":"Hsu KS, Zhao X, Cheng X, Guan D, Mahabeleshwar GH, Liu Y et al (2017) Dual regulation of Stat1 and Stat3 by the tumor suppressor protein PML contributes to interferon \u03b1-mediated inhibition of angiogenesis. J Biol Chem 292:10048\u201310060","journal-title":"J Biol Chem"},{"key":"10456_CR23","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1002\/1878-0261.13501","volume":"17","author":"AP Vogiatzoglou","year":"2023","unstructured":"Vogiatzoglou AP, Spanou S, Sachini N, Drakos E, Nikolaou C, Makatounakis T et al (2023) Promyelocytic leukemia protein regulates angiogenesis and epithelial-mesenchymal transition to limit metastasis in MDA-MB-231 breast cancer cells. Mol Oncol 17:2090\u20132108","journal-title":"Mol Oncol"},{"key":"10456_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fmolb.2020.00019","volume":"7","author":"W Dai","year":"2020","unstructured":"Dai W, Liu J, Liu B, Li Q, Sang Q, Li YY (2020) Systematical Analysis of the Cancer Genome Atlas Database Reveals EMCN\/MUC15 Combination as a Prognostic Signature for Gastric Cancer. Front Mol Biosci 7:19","journal-title":"Front Mol Biosci"},{"key":"10456_CR25","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12967-022-03649-4","volume":"20","author":"G Zhang","year":"2022","unstructured":"Zhang G, Li M, Zhou D, Yang X, Zhang W, Gao R (2022) Loss of endothelial EMCN drives tumor lung metastasis through the premetastatic niche. J Transl Med 20:446","journal-title":"J Transl Med"},{"key":"10456_CR26","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1002\/cam4.5055","volume":"12","author":"Q Huang","year":"2023","unstructured":"Huang Q, Li XM, Sun JP, Zhou Y (2023) Tumor-derived endomucin promotes colorectal cancer proliferation and metastasis. Cancer Med 12:3222\u20133236","journal-title":"Cancer Med"},{"key":"10456_CR27","doi-asserted-by":"publisher","first-page":"17138","DOI":"10.1038\/s41598-017-16852-x","volume":"7","author":"C Park-Windhol","year":"2017","unstructured":"Park-Windhol C, Ng YS, Yang J, Primo V, Saint-Geniez M (2017) D\u2019Amore. Endomucin inhibits VEGF-induced endothelial cell migration, growth, and morphogenesis by modulating VEGFR2 signaling. Sci Rep 7:17138","journal-title":"Sci Rep"},{"key":"10456_CR28","doi-asserted-by":"publisher","first-page":"790804","DOI":"10.3389\/fmolb.2021.790804","volume":"8","author":"G Zhang","year":"2021","unstructured":"Zhang G, Zhang L, Sun S, Chen M (2021) Identification of a Novel Defined Immune-Autophagy-Related Gene Signature Associated With Clinical and Prognostic Features of Kidney Renal Clear Cell Carcinoma. Front Mol Biosci 8:790804","journal-title":"Front Mol Biosci"},{"key":"10456_CR29","doi-asserted-by":"publisher","first-page":"e21776","DOI":"10.1096\/fj.202100235R","volume":"35","author":"J Zheng","year":"2021","unstructured":"Zheng J, Yang T, Gao S, Cheng M, Shao Y, Xi Y et al (2021) miR-148a-3p silences the CANX\/MHC-I pathway and impairs CD8(+) T cell-mediated immune attack in colorectal cancer. Faseb j 35:e21776","journal-title":"Faseb j"},{"key":"10456_CR30","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.lungcan.2015.08.015","volume":"90","author":"M Kobayashi","year":"2015","unstructured":"Kobayashi M, Nagashio R, Jiang SX, Saito K, Tsuchiya B, Ryuge S et al (2015) Calnexin is a novel sero-diagnostic marker for lung cancer. Lung Cancer 90:342\u2013345","journal-title":"Lung Cancer"},{"issue":"1","key":"10456_CR31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cardiores.2004.06.010","volume":"64","author":"D Ivanov","year":"2004","unstructured":"Ivanov D, Philippova M, Tkachuk V et al (2004) T-cadherin (CDH13) is a negative regulator of angiogenesis in vivo and in vitro. Cardiovasc Res 64(1):156\u2013163","journal-title":"Cardiovasc Res"},{"issue":"44","key":"10456_CR32","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1038\/onc.2016.113","volume":"35","author":"J Zhong","year":"2016","unstructured":"Zhong J, Jiang L, Cheng H et al (2016) T-cadherin promotes tumor angiogenesis via activation of the PI3K\/Akt pathway in endothelial cells. Oncogene 35(44):5795\u20135805","journal-title":"Oncogene"},{"issue":"3","key":"10456_CR33","first-page":"397","volume":"20","author":"JH Ahn","year":"2013","unstructured":"Ahn JH, Lee YJ, Kim YJ et al (2013) Sphingosine kinase 1 is a novel target of hypoxia-inducible factor-1\u03b1 in thyroid cancer. Endocr Relat Cancer 20(3):397\u2013409","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"10456_CR34","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1158\/0008-5472.CAN-11-2167","volume":"72","author":"M Nagahashi","year":"2012","unstructured":"Nagahashi M, Ramachandran S, Kim EY et al (2012) Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. Cancer Res 72(3):726\u2013735","journal-title":"Cancer Res"},{"issue":"5","key":"10456_CR35","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/ATVBAHA.120.313131","volume":"40","author":"J Chen","year":"2020","unstructured":"Chen J, Zhang L, Zhou Q et al (2020) Endomucin modulates VEGFR2 internalization and signaling in endothelial cells. Arterioscler Thromb Vasc Biol 40(5):1234\u20131246","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10456_CR36","first-page":"2315","volume":"127","author":"K Xu","year":"2017","unstructured":"Xu K, Cao Y, Liu Y et al (2017) Endomucin prevents leukocyte\u2013endothelial adhesion and protects against vascular leakage during inflammation. J Clin Invest 127(6):2315\u20132326","journal-title":"J Clin Invest"},{"issue":"11","key":"10456_CR37","first-page":"7194","volume":"13","author":"Z Wang","year":"1993","unstructured":"Wang Z, Day N, Trifillis P et al (1993) Calnexin retains unassembled major histocompatibility complex class I heavy chains in the endoplasmic reticulum. Mol Cell Biol 13(11):7194\u20137204","journal-title":"Mol Cell Biol"},{"issue":"6","key":"10456_CR38","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","volume":"15","author":"D Fukumura","year":"2018","unstructured":"Fukumura D, Kloepper J, Amoozgar Z et al (2018) Enhancing cancer immunotherapy through nanotechnology-mediated tumor vascular normalization. Nat Rev Clin Oncol 15(6):325\u2013340","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"10456_CR39","first-page":"667","volume":"6","author":"R Bernardi","year":"2006","unstructured":"Bernardi R, Guarnieri D, Pandolfi PP (2006) PML nuclear bodies: endowing tumor suppression with dignity. Nat Rev Cancer 6(9):667\u2013677","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10456_CR40","first-page":"535","volume":"25","author":"Y Wang","year":"2018","unstructured":"Wang Y, Xing Y, Liu Y et al (2018) Promyelocytic leukemia protein suppresses tumor growth in thyroid cancer. Endocr Relat Cancer 25(5):535\u2013546","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"10456_CR41","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1056\/NEJMoa1406470","volume":"372","author":"M Schlumberger","year":"2015","unstructured":"Schlumberger M, Tahara M, Wirth LJ et al (2015) Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. N Engl J Med 372(7):621\u2013630","journal-title":"N Engl J Med"},{"key":"10456_CR42","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4103\/wjtcm.wjtcm_42_21","volume":"8","author":"MM Wei","year":"2022","unstructured":"Wei MM, Wang SS, Zheng JL et al (2022) Herbal medicine teng-long-bu-zhong-tang inhibitsthe growth of human RKO colorectal cancer by regulating apoptosis, senescence, and angiogenesis. World J Tradit Chin Med 8:110\u2013114","journal-title":"World J Tradit Chin Med"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10456-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-026-10456-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10456-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:03:46Z","timestamp":1790381026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-026-10456-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,19]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10456"],"URL":"https:\/\/doi.org\/10.1007\/s00405-026-10456-w","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,19]]},"assertion":[{"value":"26 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted with approval from the Ethics Committee of Shanxi Bethune Hospital (YXLL-2024-124). This study was conducted in accordance with the declaration of Helsinki. Written informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}